Infliximab and/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease

Yoshie Hagihara, Satoko Ohfuji, Kenji Watanabe^*, Hirokazu Yamagami, Wakaba Fukushima, Kazuhiro Maeda, Noriko Kamata, Mitsue Sogawa, Masatsugu Shiba, Tetsuya Tanigawa, Kazunari Tominaga, Toshio Watanabe, Yasuhiro Fujiwara, Yoshio Hirota, Tetsuo Arakawa